Pyrovalerone

CHEMBL201960 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

245.4 g/mol

LogP

3.8

Phase

4

Pyrovalerone is a psychostimulant cathinone derivative that inhibits the reuptake of dopamine and norepinephrine by blocking their respective monoamine transporters, producing CNS stimulation, increased alertness, and euphoria similar to cocaine. It was briefly investigated as a treatment for fatigue and lethargy but is now a controlled substance due to its significant abuse potential.

分子量

245.3600 g/mol

LogP

3.80

TPSA

20.30 Å²

リピンスキーの五則

適合

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCC(C(=O)c1ccc(C)cc1)N1CCCC1

InChI

InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3

Molecular Formula

C16H23NO

HBD / HBA

- / 2

回転可能結合数

5

重原子数

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Pyrovalerone is a psychostimulant cathinone derivative that inhibits the reuptake of dopamine and norepinephrine by blocking their respective monoamine transporters, producing CNS stimulation, increased alertness, and euphoria similar to cocaine. It was briefly investigated as a treatment for fatigue and lethargy but is now a controlled substance due to its significant abuse potential.

Yes, Pyrovalerone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL201960. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 14373. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Pyrovalerone PillFYIで

構造

クイックデータ

分子式: C16H23NO

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.